Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis

Active serpiginous choroiditis (SC) is a vision-threatening condition which requires intensive treatment using corticosteroids and/or immunosuppressives, especially if the lesions are involving or encroaching on the macula. Use of oral and intravenous high-dose steroids are contraindicated in uncont...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghose, Avirupa, Bhende, Promod S, Biswas, Jyotirmoy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5151163/
https://www.ncbi.nlm.nih.gov/pubmed/27853021
http://dx.doi.org/10.4103/0301-4738.194335
_version_ 1782474336064503808
author Ghose, Avirupa
Bhende, Promod S
Biswas, Jyotirmoy
author_facet Ghose, Avirupa
Bhende, Promod S
Biswas, Jyotirmoy
author_sort Ghose, Avirupa
collection PubMed
description Active serpiginous choroiditis (SC) is a vision-threatening condition which requires intensive treatment using corticosteroids and/or immunosuppressives, especially if the lesions are involving or encroaching on the macula. Use of oral and intravenous high-dose steroids are contraindicated in uncontrolled diabetics. Intravitreal steroid delivers a localized dose in such situations. This case report highlights the efficacy of reduced dose of intravitreal triamcinolone acetonide (2 mg) in the treatment of active SC.
format Online
Article
Text
id pubmed-5151163
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-51511632016-12-20 Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis Ghose, Avirupa Bhende, Promod S Biswas, Jyotirmoy Indian J Ophthalmol Brief Communication Active serpiginous choroiditis (SC) is a vision-threatening condition which requires intensive treatment using corticosteroids and/or immunosuppressives, especially if the lesions are involving or encroaching on the macula. Use of oral and intravenous high-dose steroids are contraindicated in uncontrolled diabetics. Intravitreal steroid delivers a localized dose in such situations. This case report highlights the efficacy of reduced dose of intravitreal triamcinolone acetonide (2 mg) in the treatment of active SC. Medknow Publications & Media Pvt Ltd 2016-09 /pmc/articles/PMC5151163/ /pubmed/27853021 http://dx.doi.org/10.4103/0301-4738.194335 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Brief Communication
Ghose, Avirupa
Bhende, Promod S
Biswas, Jyotirmoy
Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis
title Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis
title_full Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis
title_fullStr Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis
title_full_unstemmed Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis
title_short Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis
title_sort efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5151163/
https://www.ncbi.nlm.nih.gov/pubmed/27853021
http://dx.doi.org/10.4103/0301-4738.194335
work_keys_str_mv AT ghoseavirupa efficacyofreduceddoseofintravitrealtriamcinoloneacetonideinacaseofactiveserpiginouschoroiditis
AT bhendepromods efficacyofreduceddoseofintravitrealtriamcinoloneacetonideinacaseofactiveserpiginouschoroiditis
AT biswasjyotirmoy efficacyofreduceddoseofintravitrealtriamcinoloneacetonideinacaseofactiveserpiginouschoroiditis

Ejemplares similares